CFTR and cystic fibrosis: MassARRAY has been evaluated for screening of SMA [9], detection of CFTR causing variants in previously genotyped cystic fibrosis (CF) patients [11] and in patients with non-syndromic hearing loss [12] and Fabry disease [13].